ipilimumab
bms
['melanoma']
day 2, here we go!!! see you at the #melanoma session and s exciting #til talk! #esmo22 
Melanoma+Cell Therapy Oncologist @MSKCancerCenter| Cornell/DukeMed/ MGH IM/MSKCC Onc alum | FCOI: https://t.co/kwtet64Pe4